Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation

for the EINSTEIN-Jr. Phase 3 Investigators, Guy Young, Anthonie W.A. Lensing, Paul Monagle, Christoph Male, Kirstin Thelen, Stefan Willmann, Joseph S. Palumbo, Riten Kumar, Ildar Nurmeev, Kerry Hege, Fanny Bajolle, Philip Connor, Hélène L. Hooimeijer, Marcela Torres, Anthony K.C. Chan, Gili Kenet, Susanne Holzhauer, Amparo Santamaría, Pascal AmedroJan Beyer-Westendorf, Ida Martinelli, M. Patricia Massicotte, William T. Smith, Scott D. Berkowitz, Stephan Schmidt, Victoria Price, Martin H. Prins, Dagmar Kubitza

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation'. Together they form a unique fingerprint.

Medicine & Life Sciences